MP80-16 QUALITY OF LIFE IN NEUROGENIC BLADDER PATIENTS AFTER SUPRAPUBIC TUBE PLACEMENT

Abstract

You have accessJournal of UrologyUrodynamics/Incontinence/Female Urology: Neurogenic Voiding Dysfunction1 Apr 2014MP80-16 QUALITY OF LIFE IN NEUROGENIC BLADDER PATIENTS AFTER SUPRAPUBIC TUBE PLACEMENT Rebecca Lavelle, Chasta Bacsu, Louise A. Gliga, and Gary E. Lemack Rebecca LavelleRebecca Lavelle More articles by this author , Chasta BacsuChasta Bacsu More articles by this author , Louise A. GligaLouise A. Gliga More articles by this author , and Gary E. LemackGary E. Lemack More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2014.02.2539AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Suprapubic catheterization (SPC) can be an effective means of managing complex patients with neurogenic bladder (NGB) conditions in which other options are unfeasible or impractical. SPC is often chosen by the patient and the clinician to improve effective bladder emptying and quality of life (QoL). This study aims to evaluate patient satisfaction in patients with NGB who have elected to undergo SPC, as well as assess adverse events (AEs) related to the procedure. METHODS This is a retrospective chart review utilizing data from an IRB approved database of patients with a variety of NGB conditions followed by a single surgeon from 1/1/2003 to 6/30/2013. Patients who underwent SPC placement (all done under anesthesia) were invited to complete a validated, single item Patient Global Impression of Improvement (PGI-I) questionnaire. Success or positive response was defined as 1 or 2 on a scale of 1-7. Demographic information and AEs (Clavien classification IIIb or greater) were collected from the database. Patients were excluded from questionnaire mailing if they were not English speaking or deceased, though were included in assessment of adverse events. RESULTS Of the 128 patients who underwent SPC, 105 patients (64 female, 41 male) fit the inclusion criteria and were sent the PGI-I questionnaire. Response rate was 44.8% (47/105). Mean age at the time of SPC placement was 54.9 years. Mean follow up was 25.1 months (1-120). Overall, 53 pts had MS, 26 had SCI, 4 had PD, 22 had other neurologic disorders (cerebrovascular accident, cerebral palsy, brain tumor, seizure disorder, transverse myelitis). Overall, success was seen in 41/47 patients (87.2%). Only 6.4% (3/47) patients reported a negative PGI-I (score 5-7/7). An early postoperative complication (within 30 days of surgery) was seen in 1/128 patients (0.08%) and consisted of bowel perforation requiring small bowel resection. CONCLUSIONS SPC is an effective solution in many carefully selected patients with NGB conditions. Over 85% considered the SPC to have improved their urological quality of life with a mean follow-up of over 2 years. Adverse events are rare, though can be particularly serious in this group of neurologically impaired patients. © 2014FiguresReferencesRelatedDetails Volume 191Issue 4SApril 2014Page: e943-e944 Advertisement Copyright & Permissions© 2014MetricsAuthor Information Rebecca Lavelle More articles by this author Chasta Bacsu More articles by this author Louise A. Gliga More articles by this author Gary E. Lemack More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...